|
The value of
radiotherapy adjuvant to surgery was first reported by
Walker in
1978.
Great strides have
been made since, including radiosurgery.
Photon, electron,
neutron, and proton radiation beams are all in clinical use. The accuracy
has improved with development of three dimensional techniques and image
fusion.
Radiotherapy
plays a very important role in the management of gliomas, as it can reach
where surgeon's hands do not.
Principles of Radiotherapy:
The higher the dose of radiation delivered ,
better is the tumor control.
The lower the dose to the surrounding normal
tissues, the lower is the associated morbidity.
Hypoxic tumor cells, usually in the center of
the tumor, are relatively radioresistant, and the lesser tumor volume,
better is the effectiveness of radiation. Surgical excision of these tumor
cells, and tumor debulking adds to the benefits of radiotherapy.
Delays between surgery and radiotherapy
should be avoided as it reduces the potential repopulation of tumor cells.
Forms of Radiotherapy:
The types of radiation are often X-rays from
the linear accelerator, and gamma rays from the decay of certain
radioactive materials like cobalt-60 and cesium-137. Other types include,
use of electron, neutron, and charged particles.
Broadly, radiotherapy can be categorized into
external beam radiation therapy (EBRT) or teletherapy, and brachytherapy.
Teletherapy(EBRT), the most commonly used radiotherapy in CNS, refers
to the projection through space of x-rays or gamma rays aimed at a target.
The standard machines for administering teletherapy are the cobalt-60
machine and the linear accelerator.
When deep X-ray
therapy was used, the result were poor and morbidity was high due to non
uniform dose distribution resulting in more radiation dose to normal brain
tissue and bone necrosis due to increased absorption of radiation by bone.
Since the introduction of Telecobalt there was significant
improvement in disease control with drastic reduction in complication
rate. The cobalt-60 machine relies on the radioactive decay of cobalt for
the production of gamma rays. Employing a system of field-shaping devices
and custom designed blocks, the cobalt machine can also be used to obtain
shaped fields for precision treatment.
With the
introduction of mega voltage X-ray machine like Linear Accelerator,
results have improved further with even greater reduction in morbidity.
The advantages of mega voltage X-ray machine are greater beam definition,
lesser scatter radiation, increased penetration resulting in better depth
dose and bone and scalp sparing effect.
Radiosurgery
is a recent addition. It refers to the use of an extremely precise and
well delineated beam of radiation that generates lesions within the brain.
Aim of radio
surgery is to deliver a very high single dose of radiation precisely to a
well defined target, to produce blood vessel thrombosis and sclerosis, to
promote tissue necrosis resulting in inactivation of tumor or obliteration
of vascular malformation without physical removal.
Stereotaxy is used for precise localization.
When stereo tactic radiation is given as a large single dose it is called
stereotactic
radiosurgery.
When stereo tactic radiation is fractionated, it is called
stereotactic radiotherapy.
Stereo tactic
treatment can be given with a gamma knife which is dedicated tele
cobalt unit having multiple pencil beams of gamma irradiation from Co60
source or X-knife which is a Linear Accelerator with a attachment
of special cones to deliver pencil beams. Localization is done using
special head rings fixed to the head to the patient. Dose varies from 12
-25Gy as a single fraction.
Many recommend
stereotactic radiosurgery as the first line of treatment for AVMs. Other
indications for Stereotactic radiosurgery are 1. Open surgery risky due to
medical reasons, 2. Recurrent/residual tumors following previous surgery,
3. Open surgery is risky due to location of lesion, 4. Patient who refuses
open surgery.
Brachytherapy is
another form of radiotherapy used in CNS. It refers to continuous
low-dose-rate irradiation such as that generated from radioisotopes,
implanted directly into tumor, either temporarily or permanently. The most
common form of brachytherapy is the interstitial implantation of
radioactive iodine-125 or iridium-192 as a component of the treatment of
supratentorial malignant gliomas. This allows high dose delivery to the
target while minimizing exposure to the surrounding normal tissue. This is
limited by tumor volume and the location. The main indication is the post
EBRT recurrence.
The use of brachytherapy is
controversial, since the results of
stereotactic radiotherapy and brachytherapy are similar.
Intraoperative Radiotherapy(IORT)
is the delivery of a single large dose of radiation using electron beam or
low energy X-rays during surgery. It is indicated for recurrent tumors as
well as primary tumors as a supplement to EBRT. The dose is determined by
the tumor volume and previous radiation. The preliminary reports are
encouraging.
Conformal
three-dimensional radiation uses high-dose radiation beams shaped to
match the shape of the glioma. This technique is highly targeted and, in
certain cases, may even be used for patients who have had previous
radiotherapy.
Hyperfractionated radiation uses many small radiation doses to deliver
a high total dosage of radiation.
A balloon
catheter (GliaSite) that delivers radiation to the tumor cavity after
surgery is showing promise.
Radiobiology:
The interaction
of ionizing radiation with biological material proceeds through several
stages resulting in wide variety of biological end effects. Ionizing
radiation interact with molecules producing excitation and ionization. The
chemical changes in irradiated molecule can be direct or indirect. Since
water forms > 70% most of the indirect action involves water molecules.
Radiation results in 2 types of cell death. Reproduction death occurs in
dividing cells and interphase death not restricted to proliferative cells.
Neurons which are not capable of cell division undergo interphase death.
Rapidly
dividing cells are more radiosensitive compared to slowly dividing cells.
CNS tumor with slowly dividing cells is less radiosensitive compared to
epithelial tumor. Since cells show variety of sensation in different
phases of cell cycle, fractionated radiotherapy is given in an attempt to
attack more and more cells in the sensitive phase of cell cycle.
Fractionation also helps normal cell recovering because of differential
recovery of normal and tumor cells. As the number of fraction increases
the total dose has to be increased because of recovery of cells from sub
lethal damage resulting in wastage of radiation. But when large single
dose is given the damage to normal tissue is the same as the tumor tissue
and hence normal tissue cannot be included with target volume. This is the
basic principle of stereo tactic radio surgery which involves giving a
large single dose to the lesion resulting in necrosis of the treated area.
Effects of
radiation on the brain:
Large single
dose or radiation causes brain death within hours. There is wide spread
increase in vascular permeability and increase in intracranial tension. At
dose levels used in therapy the same phenomenon occurs to a lesser degree.
Acute
reaction occur during or immediately after a course of irradiation
(within 2 weeks). There may be headache due to increased pressure for
first few fractions. During the acute phase, blood vessels, nerve cells
and glial cells are injured directly. Vascular changes contribute to
further cell degeneration. There may be reduction of conscious level and
worsening of focal neurological signs. These phenomena are rarely seen
today due to liberal use of Dexamathosone and due to provision of shunts.
Delayed
reaction may be " early delayed" (subacute) appearing a few weeks to a
few months (6-12 weeks) after radiation or "late delayed" starting month
or years (4-40 months) later.
The
" early
delayed" (subacute)
reaction is
usually one of transient demyelination due to temporary depletion of
oligodendroglia. The somnolence syndrome represents an early delayed
radiation reaction in the brain and in characterized by transient period
of exhaustion at 2 weeks, drowsiness, lethargy and anorexia at 4-6 weeks
after radiation. It is usually reversible over a period of 1-2 weeks. 4-8
weeks after radiation, there may be rapidly progressive ataxia, cranial
nerve and focal neuro deficits and nystagmus and takes longer (1-2mths) to
recover.
Late delayed
damage is the most feared complication and vary depending on the region
irradiated. This results from the continuation of oligodendroglial loss
and endothelial damage leading to demyelination and necrosis of while
matter. Less severe forms of late damage may occur in children as
cognitive impairment and is age related. Midline structure like midbrain,
brain stem and hypothalamus are particularly vulnerable CT scan of brain
of long term survivors of large field radiation show generalized atrophy
with wide sulci and large ventricle, but it does not seem to be associated
with noticeable deterioration on patients intellectual status.
Most are
irreversible.
Delayed spinal cord
damages include, acute ( over several hours) complete
quadriplegia/paraplegia, LMN syndrome (muscle atrophy, areflexia,
fasciculations) developing over weeks, and Chronic progressive myelitis.
Additional form of delayed
radiation injury, is the development of second malignancy of a different
histologic type within the irradiated field, following years after
irradiation.
Pathology:
Radiation injury is characterized by a shrinking and shriveling of the
cortex. In the spinal cord, the cord is thinned out. Histologically there
are areas of confluent coagulative necrosis of the white matter, vascular
thickening, telangiectasia and vascular proliferation.
Imaging: There are
no radiographic changes that are pathognomonic of radionecrosis. Isotope
scan may help. However, histologic confirmation is required in most
instances.
Clinical applications:
Goals of
radiotherapy are curative and palliative. In curative radiotherapy. some
degree of risk is accepted for a reasonable probability of permanent
eradication of the malignancy. In medulloblastoma, risks of radiation
injury to cognition, a diminution of bone growth, or other toxicities may
be acceptable for a 60%-80% probability of cure. In palliative
radiotherapy, the intent is to ameliorate the symptoms and it would be a
short course avoiding radiation induced CNS toxicity.
Currently, the whole brain radiotherapy for the treatment of GBM is no
longer practiced. Localized field covering 2 - 3cm area around the
peritumoral edema is the standard portal up to 45Gy. This is followed by
the booster dose to the reduced field with 1.5-2.0cm around the tumor.
Doses of radiation
are typically prescribed in cGy (centiGray). The cGy, a unit of
absorbed dose in tissue, became the standard dose unit of radiation in
1980 when it replaced the term rad (radiation absorbed dose).
Appropriate dose depends on radiation tolerance of the surrounding normal
tissue and the data concerning the dose response of the tumor to
radiation.
The dose fraction limits for brain necrosis are approximately 35 Gy/10
fractions or 60Gy/30 fractions. CNS tissue is late reacting tissue and the
reaction is more related to dose per fraction as well as total dose. Hence
in radical radiotherapy where patient is expected to survive long, daily
dose should not exceed 180-200cGy for adults and 150cGy for children The
total dose should not exceed 60-65 Gy.
Next is the appropriate
volume for irradiation ( amount of tissue that needs to be encompassed
in the radiation beam). This is ascertained by appropriate imaging
studies, with a margin, and a sound understanding of the patterns of
spread of the tumor. For example, in medulloblastoma which is known to
seed to the spinal axis, the volume must encompass the entire craniospinal
axis.
Finally, one must choose the
right technique. A common technique is parallel opposed lateral
beams directed at the brain. Other techniques include parallel opposed
lateral fields, and a vertex field, arc treatment, or single beams. In the
spinal malignancies, either a single posterior field, parallel opposed
anterior and posterior fields, or various angled fields.
A computer
reconstruction of the radiation dose distribution (computerized
dosimetry) is widely employed. This has
resulted in
better and accurate dose delivery minimizing the dose to surrounding
normal brain tissue and resulting in fairly uniform dose distribution to
the tumor. Imaging modality like MRI has considerably improved the
accuracy of target volume definition.
3 D
conformal treatment using multiple collimator and stereo tactic
radiation can be considered as the ultimate precision radiotherapy.
No statistically significant benefit is
noted with combined radiotherapy and chemotherapy.
Radiosensitizers: In order to increase sensitivity to radiation of
the same external dose halogenated pyrimidines can be administered during
radiotherapy. These agents are thymidine antimetabolites, which are
incorporated into the DNA of dividing cells enhancing the radio
sensitivity of these cells. Pyrimidine uptake in tumor cells is higher
(high labeling index) than in normal brain cells thus increasing the radio
sensitivity of the tumor. Treatment can be combined with accelerated
fractionation or hyper fractionation.
BUdR,
IUdR,
FUdR,
and 5-FU are some
the agents that have been used for sensitizing.
Prolonged intravenous or intra-arterial infusion are equal in their
effects. In one study glioblastomas showed a slightly better response
compared to standard radiation. In patients with anaplastic astrocytoma
a MST of more than 5 years has been reported. It is not clear whether
these results are influenced by other factors. Cytotoxicity is another
anti-tumor effect of these agents.
But prospective randomized
studies showed no significant additional effect of radiosensitizer.
Hyperthermia is being tried as an adjunct
because hyperthermic cytotoxic effects are independent of the cell-cycle
phase.
Radioenhancers:
These drugs, such as topotecan, increase the effects of radiation.
Topotecan combined with other drugs, such as thiotepa and carboplatin, may
help children with neuroblastoma and brain tumors. Efaproxiral, an
investigative agent that increases oxygen in the brain, is showing promise
as a radioenhancer.
Radiotherapy and tumor types:
Low grade
glioma: Low grade astrocytoma after complete excision do not require
post operative radiotherapy. Tumor with incomplete excision or after open
or stereo tactic biopsy require radiotherapy. Routine post operative
radiotherapy of oligodendroglioma provides marginal survival advantages.
Dose of 55-60 Gy.
High grade
glioma: Radiotherapy prolongs survival and improves quality of
life. Deficits improve in 1/3 and stabilized in ½. Usually large field
radiotherapy is followed by boost. Giving local boost beyond 70 Gy is
being tried but still should be considered as investigational.
Ependymoma:
Post operative radiotherapy is standard practice. Craniospinal
radiotherapy is controversial and is probably Indicated in high grade
tumors.
Brainstem
Radiotherapy may be given even without biopsy confirmation in
selected cases; lately, a
stereotactic biopsy is insisted upon as a prelude.. If
tumor is less than 4 cm, fractionated stereo tactic radiotherapy will
minimize dose to critical areas.
Pineal
tumor: It is necessary to do CSF and serum markers namely B-HCG
and AFB +ve markers are diagnostic of germ cell tumors and radiotherapy
and / or chemotherapy started straight away without biopsy confirmation.
If markers are negative, biopsy confirmation is advisable. If response is
good it indicated germinoma or pineoblastoma and external radiation is
continued to the whole brain for a dose of 36Gy. Hence the pineal dose is
55Gy. For histologically verified germ cell tumors, a dose of 36Gy is
given to whole brain followed by a boost dose of 20Gy. The risk of
developing spinal metastases is 13%, with brain radiotherapy alone. The
risk is reduced to 5% if spinal irradiation is given. Hence an adult
should receive craniospinal irradiation and in children and young women
spinal radiation is given only if CSF cytology is positive and when major
surgical intervention is done. Pineoblastoma is treated like germinoma and
pineocytoma is treated like glioma when histological proof is available.
Lymphoma:
Treatment is by whole brain radiation of 36Gy followed by a boost of
20Gy. Spinal radiation is given when CSF is positive. Median survival is
10-18 months. Long term cure is rare with radiation alone. Hence lymphoma
needs adjuvant chemotherapy also. More recently chemotherapy is tried
after surgery and radiotherapy is given later and the results are awaited.
Medulloblastoma: Radiotherapy is indicated in all patients after
surgical excision. Craniospinal radiation is essential because of high
incidence of spinal seeding. Whole brain is treated with a dose of 30-36Gy
in 20 fractions followed by a boost of 15-20Gy. Spinal cord is given a
dose of 30-36Gy and in children <5 years a dose of 25-30Gy is given. The
value of adjuvant chemotherapy in low risk patients is not established,
but is indicated in high risk patients. Trials are ongoing in which
chemotherapy is given prior to radiotherapy in high risk patients.
Pituitary
lesions: In craniopharyngioma, tumor control is better with
surgery and radiotherapy than with surgery alone. Dose 50-55Gy in 25-30
fractions. In pituitary adenomas surgery followed by radiotherapy produces
83% 10 year progression free survival. A large proportion of patients
require hormone replacement therapy due to progressive pituitary failure.
Radiotherapy can produce optic nerve damage in 1-2%. More recently stereo
tactic radiotherapy is used for tumor of less than 4cm. And the incidence
of optic nerve damage is minimized or eliminated.
Meningioma:
After incomplete excision of begin meningioma, 5 year recurrence rate
is 30-40% and adjuvant radiotherapy reduces it to 10-25%. Radiotherapy for
inoperable tumor results in 50% progression free survival. Malignant
meningioma requires postoperative radiotherapy and the treatment is
similar to that of glioblastoma. Stereotactic biopsy is preferred whenever
possible.
Metastases:
Whole brain radiation produces neurological improvement in 35-70% of
patients. 30Gy in 10 fractions, 40Gy in 20 fractions and 50Gy in 25
fractions show no difference in results. When patient is likely to survive
for a longer time as in metastasis of renal carcinoma or thyroid
carcinoma, conventional fractionation is preferable. Solitary metastasis
or metastases up to 3 numbers may be treated with stereo tactic radio
surgery when the primary is in kidney, malignant melanoma, thyroid,
sarcoma etc.. While brain radiotherapy may be followed by boost especially
when primary is under control and there are no metastases elsewhere.
Spinal cord
tumors: Low grade gliomas in
general are not given postoperative radiotherapy after good surgical
excision without any neurological deficit. The risk of radiation
myelopathy is 5% after radical radiotherapy. The spinal cord tolerance
depends upon the length of cord irradiated. The dose is restricted to
50-55Gy for cord length of cord irradiated. The dose is restricted to
50-55Gy for cord length up to 10cm. For longer segments, dose is limited
to 45Gy. |